I was spot on about this UK growth stock. Here’s what I’d do now

Paul Summers picked this growth stock out as a possible winner last year and so has proved to be the case. What would he do now?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in veterinary services provider CVS Group (LSE: CVSG) were rising again this morning following its latest update on trading. Had I bought this growth stock when last writing about it in September, I’d be sitting on a gain of 30%. As much as I’m focused on long-term returns, that’s hardly a bad result over just four months!

Top growth stock

Its total sales grew by 9.4% to a little under £246m over the six months to the end of December. Like-for-like sales also increased by 7.8%. The latter may be slightly lower than over the same period in 2019 but I need to take into account just how bad 2020 was for most businesses.

According to CVS, this resilient performance was the result of growth in its main Practices division, coupled with higher demand at its online pharmacy and retail arm (Animed). As one might expect given the clamour for animal companions in 2020, the AIM-listed company saw an increase in new client registrations over the period.  Membership numbers of its Healthy Pet Club preventative medicine scheme also grew by 3.6% to hit 430,000. 

In other news, the company’s not-insignificant employment costs fell slightly, from 51% of total sales to 48.9%. The vet vacancy rate also declined.

To round things off, CVS Group was active on the acquisition front, purchasing four practices over the six-month period. I think this should only help to further cement its status as one of the leading veterinary services providers around. It now has more than 480 surgeries in the UK, Netherlands and Republic of Ireland. 

What now?

As far as trading is concerned, I suspect recent momentum will be sustained. All of CVS’s practices remain open, in line with guidance issued at the beginning of the third UK lockdown. Importantly, the company is now able to provide essential services relating to animal welfare rather than just emergency work.

Perhaps the biggest reason for continuing to be bullish on this growth stock, however, is that I simply can’t see the trend for pet ownership reversing. I also feel we’re unlikely to curtail spending on our furry friends, regardless of how the UK economy is performing. 

All told, the long-term prospects seem too good to me to bank profits this early. Even so, I have to be aware of the risks involved.

Volatility ahead? 

One thing that might lead the share price to lose steam is a good, old-fashioned bout of profit-taking. This wouldn’t feel unreasonable. After all, the value of CVS has more than doubled since the dark days of March. A forecast price-to-earnings (P/E) ratio of 27 suggests a lot of good news is already priced in. 

CVS certainly has form when it comes to violent, and protracted, share price swings. Between November 2017 and January 2019, the valuation of the company plunged as it struggled to recruit vets in light of the Brexit referendum outcome. While our departure from the EU might be one-off event, this doesn’t negate the fact that such falls are possible.

So, I wouldn’t sell had I bought a few months back. But while I do still think the shares could reward those with long investing horizons, I wouldn’t buy this growth stock today. I’m cautious over how much further the price could go in 2021 alone. As always, being sufficiently diversified elsewhere is key, regardless of how encouraging the outlook may be.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Paul Summers has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Just released: Share Advisor’s latest ‘Hold’ recommendation [PREMIUM PICKS]

In our Share Advisor newsletter service, we provide buy, sell, and hold guidance for our universe of recommendations.

Read more »

Investing Articles

Investing £5 a day could help me build a second income of £329 a month!

This Fool explains how £5 a day, or one less takeaway coffee, could help her build a monthly second income…

Read more »

Smart young brown businesswoman working from home on a laptop
Investing Articles

2 FTSE income stocks investors should consider buying in April

Income stocks are a great way to build wealth. Our writer details two picks she believes investors should consider snapping…

Read more »

Investing Articles

What might the 5-year price chart tell us about BT shares?

Christopher Ruane considers what clues the long-term performance of BT shares might offer him about business performance and whether to…

Read more »